6
Oct
2026

Rezon Bio

Exhibitor at CPHI Milan 2026 stand 12J42, BioProduction
About Us

Rezon Bio is a biologics CDMO specializing in mammalian drug substance development and GMP manufacturing, with drug product coordinated via qualified external partners. 

Headquartered in Poland, the company operates two mirrored-capability facilities in Gdańsk and Duchnice audited by EMA and FDA. Drawing on a legacy of biosimilars development and global commercialization, Rezon Bio combines proven experience, digital transparency, and cost-to-value efficiency to help clients move from concept to market with confidence.

  • Country/Region:
    Poland
  • On CPHI since:
    2025
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12J42, BioProduction

Products Featured at CPHI Milan 2026

Rezon Bio Resources (1)

  • Brochure Rezon Bio Flyer

    Mirrored equipment and capabilities, processesand analytical approaches enable seamless andrapid scale up and tech transfer projects to serveclients worldwide.